India Glycols Limited (INDIAGLYCO:NSE) Stock Forecast
Alert
Its only available to paid users.
INR 1,522.50
(+38.96%)
Based on the India Glycols Limited stock forecast from 1 analysts, the average analyst target price for India Glycols Limited is INR 1,522.50 over the next 12 months. India Glycols Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of India Glycols Limited is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, India Glycols Limited’s stock price was INR 1,095.65. India Glycols Limited’s stock price has changed by -0.91% over the past week, -1.75% over the past month and +39.96% over the last year.
No recent analyst target price found for India Glycols Limited
No recent average analyst rating found for India Glycols Limited
Company Overview India Glycols Limited
India Glycols Limited, a green petrochemical company, engages in the manufacture and sale of industrial chemicals in India. The company operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. It offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. The company also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor. In addition, it offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives. Further, the company's products find applications in pharma and healthcare, textiles, automotive, personal care, industrial and manufacturing, paints and coatings, oil and gas, food ingredients, packaging, potable spirits, and other various industries. It also exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India. Read Less
India Glycols Limited, a green petrochemical company, engages in the manufacture and sale of industrial chemicals in India. The company operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. It offers bio mono ethylene...Read More
Frequently Asked Questions About India Glycols Limited (INDIAGLYCO:NSE) Stock
Based on ratings from 1 analysts India Glycols Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 2 buy, sell and hold ratings.
INDIAGLYCO:NSE stock's dividend yield is 0.70%.
Our analysis grades INDIAGLYCO:NSE stock's dividend yield at F. This means that INDIAGLYCO:NSE stock's dividend yield is above 48% of the stocks in the Chemicals sector in the NSE exchange.
Based on this INDIAGLYCO:NSE may be a average dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for INDIAGLYCO:NSE is INR 1,522.50 over the next 12 months. The maximum analyst target price is INR 1580 while the minimum anlayst target price is INR 1465.
INDIAGLYCO:NSE stock's Price/Earning ratio is 18.10.
Our analysis grades INDIAGLYCO:NSE stock's Price / Earning ratio at C-. This means that INDIAGLYCO:NSE stock's Price/Earning ratio is above 30% of the stocks in the Chemicals sector in the NSE exchange.
Based on this INDIAGLYCO:NSE may be undervalued for its sector.
The last closing price of INDIAGLYCO:NSE's stock was INR 1,095.65.
The most recent market capitalization for INDIAGLYCO:NSE is INR 35.10B.
Based on targets from 1 analysts, the average taret price for INDIAGLYCO:NSE is projected at INR 1,522.50 over the next 12 months.
This means that INDIAGLYCO:NSE's stock price may go up by +38.96% over the next 12 months.
We can't find any ETFs which contains India Glycols Limited's stock.
As per our most recent records India Glycols Limited has 1,326 Employees.
India Glycols Limited's registered address is Plot No. 2-B, Noida, India, 201304.
You can get more information about it from India Glycols Limited's website at https://www.indiaglycols.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About India Glycols Limited (INDIAGLYCO:NSE) Stock
Based on ratings from 1 analysts India Glycols Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 2 buy, sell and hold ratings.
INDIAGLYCO:NSE stock's dividend yield is 0.70%.
Our analysis grades INDIAGLYCO:NSE stock's dividend yield at F. This means that INDIAGLYCO:NSE stock's dividend yield is above 48% of the stocks in the Chemicals sector in the NSE exchange.
Based on this INDIAGLYCO:NSE may be a average dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for INDIAGLYCO:NSE is INR 1,522.50 over the next 12 months. The maximum analyst target price is INR 1580 while the minimum anlayst target price is INR 1465.
INDIAGLYCO:NSE stock's Price/Earning ratio is 18.10.
Our analysis grades INDIAGLYCO:NSE stock's Price / Earning ratio at C-. This means that INDIAGLYCO:NSE stock's Price/Earning ratio is above 30% of the stocks in the Chemicals sector in the NSE exchange.
Based on this INDIAGLYCO:NSE may be undervalued for its sector.
The last closing price of INDIAGLYCO:NSE's stock was INR 1,095.65.
The most recent market capitalization for INDIAGLYCO:NSE is INR 35.10B.
Based on targets from 1 analysts, the average taret price for INDIAGLYCO:NSE is projected at INR 1,522.50 over the next 12 months.
This means that INDIAGLYCO:NSE's stock price may go up by +38.96% over the next 12 months.
We can't find any ETFs which contains India Glycols Limited's stock.
As per our most recent records India Glycols Limited has 1,326 Employees.
India Glycols Limited's registered address is Plot No. 2-B, Noida, India, 201304.
You can get more information about it from India Glycols Limited's website at https://www.indiaglycols.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for INDIAGLYCO:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
